Clinical Trial Update: Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating weekly docetaxel combined with CMF (cyclophosphamide, methotrexate, 5-fluorouracil) as adjuvant therapy for elderly women with high-ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED